LES LABORATOIRES SERVIER — China drug registrations and re-registration deadlines
25 certificates in the NMPA overseas-manufactured drug database (境外生产药品库), snapshot 2026-06-28. Earliest re-registration deadline: 2026-10-11.
| Approval number | Product | Certificate expires | Re-registration deadline (Art. 82) |
|---|---|---|---|
| 国药准字HJ20220034 | Irinotecan Hydrochloride Liposome Injection 盐酸伊立替康脂质体注射液 | 2027-04-11 | 2026-10-11 |
| 国药准字HJ20180013 | COVERAM 培哚普利氨氯地平片（Ⅰ） | 2027-11-15 | 2027-05-15 |
| 国药准字HJ20180014 | COVERAM 培哚普利氨氯地平片（Ⅰ） | 2027-11-15 | 2027-05-15 |
| 国药准字HJ20180015 | COVERAM 培哚普利氨氯地平片（Ⅲ） | 2027-11-15 | 2027-05-15 |
| 国药准字HJ20180016 | COVERAM 培哚普利氨氯地平片（Ⅱ） | 2027-11-15 | 2027-05-15 |
| 国药准字HJ20191023 | COVERAM 培哚普利氨氯地平片（Ⅲ） | 2027-11-15 | 2027-05-15 |
| 国药准字HJ20171296 | Natrilix 吲达帕胺缓释片 | 2028-04-24 | 2027-10-24 |
| 国药准字HJ20140220 | Vasorel 盐酸曲美他嗪片 | 2028-05-04 | 2027-11-04 |
| 国药准字HJ20140104 | Trastal 吡贝地尔缓释片 | 2028-08-01 | 2028-02-01 |
| 国药准字HJ20140105 | Trastal 吡贝地尔缓释片 | 2028-08-01 | 2028-02-01 |
| 国药准字HJ20150282 | Gliclazide Modified Release Tablets 格列齐特缓释片 | 2029-03-19 | 2028-09-19 |
| 国药准字HJ20150283 | Gliclazide Modified Release Tablets 格列齐特缓释片 | 2029-03-19 | 2028-09-19 |
| 国药准字HJ20150217 | CORLENTOR 盐酸伊伐布雷定片 | 2029-05-30 | 2028-11-30 |
| 国药准字HJ20150218 | CORLENTOR 盐酸伊伐布雷定片 | 2029-05-30 | 2028-11-30 |
| 国药准字HJ20150272 | CORLENTOR 盐酸伊伐布雷定片 | 2029-05-30 | 2028-11-30 |
| 国药准字HJ20150273 | CORLENTOR 盐酸伊伐布雷定片 | 2029-05-30 | 2028-11-30 |
| 国药准字HJ20150274 | CORLENTOR 盐酸伊伐布雷定片 | 2029-05-30 | 2028-11-30 |
| 国药准字HJ20150275 | CORLENTOR 盐酸伊伐布雷定片 | 2029-05-30 | 2028-11-30 |
| 国药准字HJ20140800 | Acertil 精氨酸培哚普利片 | 2029-09-02 | 2029-03-02 |
| 国药准字HJ20140801 | Acertil 精氨酸培哚普利片 | 2029-09-02 | 2029-03-02 |
| 国药准字HJ20140455 | ALVENOR 柑橘黄酮片 | 2029-10-24 | 2029-04-24 |
| 国药准字HJ20150581 | VALDOXAN 阿戈美拉汀片 | 2029-12-10 | 2029-06-10 |
| 国药准字HJ20150582 | VALDOXAN 阿戈美拉汀片 | 2029-12-10 | 2029-06-10 |
| 国药准字HJ20150583 | VALDOXAN 阿戈美拉汀片 | 2029-12-10 | 2029-06-10 |
| 国药准字HJ20080215 | Diamicron MR 格列齐特缓释片 | 2031-05-19 | 2030-11-19 |
Under the Provisions for Drug Registration (药品注册管理办法) Art. 82, an application to renew an overseas-manufactured drug registration is filed with the Center for Drug Evaluation no later than 6 months before the certificate expires; the filing line column is that arithmetic applied to the expiry cell. Art. 84(1): a certificate with no application by expiry is not re-registered and is cancelled at expiry. Every figure is taken from the public NMPA database as of 2026-06-28, or computed from it. Registration data changes; the NMPA portal governs. This page states no view on whether any of these products' Domestic Responsible Person (境内责任人) arrangements meet NMPA Announcement No. 137 — that cannot be determined from a public entry.